Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.

Mabuchi, Seiji; Ohmichi, Masahide; Nishio, Yukihiro; Hayasaka, Tadashi; Kimura, Akiko; Ohta, Tsuyoshi; Kawagoe, Jun; Takahashi, Kazuhiro; Yada-Hashimoto, Namiko; Seino-Noda, Hozumi; Sakata, Masahiro; Motoyama, Teiichi; Kurachi, Hirohisa; Testa, Joseph R; Tasaka, Keiichi; Murata, Yuji

Mabuchi, Seiji; Ohmichi, Masahide; Nishio, Yukihiro; Hayasaka, Tadashi; Kimura, Akiko; Ohta, Tsuyoshi; Kawagoe, Jun; Takahashi, Kazuhiro; Yada-Hashimoto, Namiko; Seino-Noda, Hozumi; Sakata, Masahiro; Motoyama, Teiichi; Kurachi, Hirohisa; Testa, Joseph R; Tasaka, Keiichi; Murata, Yuji.

Affiliation

Mabuchi S; Department of Obstetrics and Gynecology, Osaka University Medical School, Osaka, Japan.

Clin Cancer Res ; 10(22): 7645-54, 2004 Nov 15.

Article de En | MEDLINE | ID: mdl-15569997

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Facteur de transcription NF-kappa B / Paclitaxel Type d'étude: Prognostic_studies Langue: En Journal: Clin Cancer Res Sujet du journal: NEOPLASIAS Année: 2004 Type de document: Article Pays d'affiliation: Japon

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links